Farzaneh Tabrizi, MD
Family Practice · Los Gatos
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Probation - Licensee Placed on Probation
- 1 Medical Board action on record
Offices
1 location
Hospitals listed: 058496 · 059765 · El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tabrizi’s office at (408) 384-9719 to ask if they take your plan before you enroll.
California Medical Board record
Licence A64717 · Current
Licensed to practise in California · since 1998 · expires 2027-06-30 · Temple University School of Medicine. Board flags: Probation - Licensee Placed on Probation, Limitations on Practice.
Public record actions
| 2024-08-08 | Board disciplineDiscipline | Three years' probation with various terms and conditions. restrictions: prohibited from supervising physician assistants and advanced practice nurses. · 8002019057155 |
Respondent made no admissions but was charged with gross negligence in the care and treatment of one patient, and repeated negligent acts and failure to maintain adequate and accurate medical records in the care and treatment of two patients. Acceptance of this stipulated settlement is not an admission of guilt. Effective 08/08/2024, revoked, stayed, placed on three years' probation until anticipated end date of 08/07/2027. Terms and conditions include, but are not limited to, completing an education course and a medical record keeping course; submitting proof of notification of Decision and Accusation to required parties; prohibited from supervising physician assistants and advanced practice nurses; reimbursing the Board its costs of investigation and enforcement in the amount of $17,173.00; submitting quarterly declarations of compliance with all conditions of probation; complying with the Board's probation unit; prohibited from engaging in the practice of medicine in Respondent's or patient's place of residence, unless the patient resides in a skilled nursing facility or other similar licensed facility; and paying costs associated with probation monitoring.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 4.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$286,644
Medicare paid this office $286,644 for 239 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 183 | $99,435 | $109 |
| Critical care, first 30-74 minutes | 108 | $52,323 | $222 |
| Critical care, each additional 30 minutes | 78 | $34,124 | $98 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 70 | $20,158 | $141 |
| Long return visit (40+ min) | 96 | $17,734 | $114 |
See all 16 services
| Return visit (30+ min) | 183 | $99,435 | $109 |
| Critical care, first 30-74 minutes | 108 | $52,323 | $222 |
| Critical care, each additional 30 minutes | 78 | $34,124 | $98 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 70 | $20,158 | $141 |
| Long return visit (40+ min) | 96 | $17,734 | $114 |
| Urinalysis for bacteria | 128 | $13,074 | $29 |
| Complete ultrasound scan behind abdominal cavity | 61 | $12,265 | $102 |
| New patient visit (60+ min) | 70 | $10,071 | $144 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 25 | $9,574 | $234 |
| Short return visit (20+ min) | 19 | $1,686 | $80 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 30 | $1,418 | None |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 11 | $1,343 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 75 | $1,291 | $12 |
| Detection test by immunoassay with direct visual observation for influenza virus | 20 | $746 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $389 | $16 |
| Injection, ceftriaxone sodium, per 250 mg | 27 | $102 | None |
Who their Medicare patients are
239 Original Medicare patients in 2024. Average age 76 · Women 65% · Also on Medicaid 31% · Health risk score 1.09. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 62% · Coronary heart disease 55% · Diabetes 52% · Atrial fibrillation 18% · Heart failure 15% · Depression 15% · Cancer 14% · Chronic kidney disease 13% · Dementia 10% · Stroke 10% · COPD 8%.
The office billed $499,275, Medicare allowed $385,272 and paid $286,644; for 3,386 services of 31 kinds; $1,705 of it was for drugs given in the office and $284,940 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 239 | 3,386 | 76 | 1.09 | $499,275 | $286,644 |
| 2023 | 260 | 3,478 | 76 | 0.98 | $433,645 | $286,728 |
| 2022 | 237 | 3,307 | 76 | 0.95 | $368,125 | $236,154 |
| 2021 | 279 | 3,954 | 76 | 0.97 | $443,155 | $272,942 |
| 2020 | 296 | 5,608 | 75 | 0.96 | $458,090 | $242,125 |
| 2019 | 463 | 14,737 | 75 | 1.06 | $816,555 | $442,504 |
| 2018 | 546 | 15,071 | 75 | 1.09 | $897,450 | $495,750 |
| 2017 | 600 | 12,086 | 75 | 1.09 | $987,939 | $563,265 |
| 2016 | 598 | 17,475 | 74 | 1.02 | $1,316,202 | $796,661 |
| 2015 | 521 | 14,800 | 74 | 1.03 | $1,204,184 | $725,397 |
| 2014 | 358 | 6,209 | 74 | 0.96 | $1,027,192 | $496,517 |
| 2013 | 68 | 1,282 | 76 | 1.13 | $194,465 | $109,790 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Long return visit (40+ min) | 196 | $130,016 | $157 |
| Return visit (30+ min) | 57 | $30,946 | $114 |
| Critical care, first 30-74 minutes | 61 | $26,016 | $248 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 52 | $18,653 | $153 |
| New patient visit (60+ min) | 93 | $15,155 | $163 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 35 | $15,132 | $261 |
| Critical care, each additional 30 minutes | 36 | $12,152 | $108 |
| Complete ultrasound scan behind abdominal cavity | 43 | $8,817 | $113 |
| Urinalysis for bacteria | 89 | $7,639 | $29 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 11 | $5,713 | $476 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 60 | $4,933 | None |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, each additional 5.0 cm or less | 11 | $4,892 | $163 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 48 | $816 | $13 |
2022: 12 services
| Long return visit (40+ min) | 157 | $86,717 | $159 |
| Return visit (30+ min) | 95 | $58,050 | $114 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 55 | $19,988 | $157 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 22 | $18,456 | $264 |
| New patient visit (60+ min) | 90 | $15,082 | $168 |
| Complete ultrasound scan behind abdominal cavity | 33 | $7,911 | $113 |
| Urinalysis for bacteria | 81 | $5,979 | $30 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 71 | $5,759 | None |
| Critical care, first 30-74 minutes | 15 | $3,736 | $249 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 46 | $759 | $14 |
| Injection of drug or substance under skin or into muscle | 17 | $427 | $14 |
| Injection, ketorolac tromethamine, per 15 mg | 13 | $86 | None |
2021: 15 services
| Return visit (30+ min) | 202 | $132,192 | $118 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 59 | $20,702 | $173 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 42 | $20,116 | $276 |
| Ct scan of abdomen and pelvis before and after contrast | 33 | $15,217 | $400 |
| Long return visit (40+ min) | 65 | $14,343 | $165 |
| New patient visit (45+ min) | 65 | $8,587 | $132 |
| New patient visit (60+ min) | 43 | $8,388 | $195 |
| Complete ultrasound scan behind abdominal cavity | 39 | $7,366 | $119 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 14 | $6,823 | $487 |
| Urinalysis for bacteria | 91 | $6,686 | $30 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 87 | $6,479 | None |
| Critical care, first 30-74 minutes | 17 | $4,460 | $235 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 59 | $1,044 | $14 |
| Injection of drug or substance under skin or into muscle | 32 | $906 | $13 |
| Injection, ketorolac tromethamine, per 15 mg | 15 | $53 | None |
2020: 21 services
| Return visit (30+ min) | 227 | $84,822 | $92 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 79 | $26,135 | $161 |
| Critical care, first 30-74 minutes | 69 | $21,129 | $211 |
| Ct scan of abdomen and pelvis before and after contrast | 44 | $18,025 | $368 |
| Critical care, each additional 30 minutes | 53 | $16,623 | $107 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 30 | $13,611 | $257 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 126 | $10,680 | None |
| New patient visit (45+ min) | 97 | $9,331 | $96 |
| Ct scan of chest before and after contrast | 31 | $8,188 | $227 |
| Urinalysis for bacteria | 77 | $6,051 | $28 |
| Complete ultrasound scan behind abdominal cavity | 15 | $2,135 | $107 |
| Injection of drug or substance under skin or into muscle | 40 | $1,468 | $12 |
| Short return visit (20+ min) | 14 | $1,105 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 38 | $673 | $16 |
| Administration of influenza virus vaccine | 13 | $272 | $21 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 15 | $260 | $16 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 13 | $255 | $20 |
| Injection, ceftriaxone sodium, per 250 mg | 38 | $204 | None |
| Injection, ketorolac tromethamine, per 15 mg | 22 | $129 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 24 | $66 | None |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 19 | $32 | None |
2019: 27 services
| Return visit (30+ min) | 316 | $92,961 | $90 |
| Critical care, first 30-74 minutes | 144 | $77,194 | $232 |
| Critical care, each additional 30 minutes | 107 | $60,439 | $105 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 138 | $55,069 | $169 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 58 | $29,683 | $254 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 196 | $22,702 | None |
| Ct scan of abdomen and pelvis before and after contrast | 43 | $19,066 | $353 |
| New patient visit (45+ min) | 155 | $17,617 | $114 |
| Ct scan of chest before and after contrast | 42 | $10,736 | $228 |
| Short return visit (20+ min) | 44 | $8,165 | $66 |
| Urinalysis for bacteria | 102 | $6,601 | $27 |
| Injection of drug or substance under skin or into muscle | 81 | $6,002 | $16 |
| Complicated drainage of external ear abscess or blood accumulation | 23 | $5,963 | $239 |
| Ct scan of head or brain before and after contrast | 12 | $2,425 | $187 |
| Ct scan head or brain without contrast | 15 | $2,126 | $112 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 105 | $1,857 | $15 |
| Injection, ceftriaxone sodium, per 250 mg | 133 | $905 | None |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 42 | $810 | $16 |
| X-ray of knee, 4 or more views | 11 | $747 | $37 |
| Injection, ketorolac tromethamine, per 15 mg | 36 | $673 | None |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 33 | $639 | $19 |
| Administration of influenza virus vaccine | 26 | $533 | $21 |
| Detection test by immunoassay with direct visual observation for influenza virus | 16 | $519 | $16 |
| Blood test, comprehensive group of blood chemicals | 20 | $311 | $12 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 85 | $170 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 22 | $132 | None |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 53 | $113 | None |
2018: 28 services
| Critical care, each additional 30 minutes | 143 | $107,071 | $103 |
| Return visit (30+ min) | 353 | $91,203 | $87 |
| Critical care, first 30-74 minutes | 165 | $88,257 | $223 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 162 | $47,572 | $172 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 71 | $30,603 | $249 |
| New patient visit (45+ min) | 201 | $23,891 | $119 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 253 | $22,105 | None |
| Ct scan of abdomen and pelvis before and after contrast | 36 | $14,342 | $341 |
| Ct scan of chest before and after contrast | 45 | $10,721 | $223 |
| Injection of drug or substance under skin or into muscle | 90 | $6,897 | $19 |
| Complicated drainage of external ear abscess or blood accumulation | 20 | $5,271 | $211 |
| Complete ultrasound scan behind abdominal cavity | 31 | $4,788 | $106 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 11 | $4,758 | $433 |
| Short return visit (20+ min) | 18 | $3,657 | $65 |
| Urinalysis for bacteria | 124 | $2,881 | $11 |
| Ct scan head or brain without contrast | 18 | $2,206 | $110 |
| Application of lower and upper arm splint | 21 | $1,686 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 81 | $1,490 | $16 |
| Injection, ceftriaxone sodium, per 250 mg | 191 | $1,139 | None |
| Detection test by immunoassay with direct visual observation for influenza virus | 33 | $1,038 | $16 |
| Administration of influenza virus vaccine | 39 | $1,003 | $26 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 51 | $940 | $16 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 42 | $829 | $19 |
| Injection, ketorolac tromethamine, per 15 mg | 54 | $641 | None |
| X-ray of foot, minimum of 3 views | 11 | $337 | $26 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 99 | $178 | None |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 36 | $102 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 24 | $71 | None |
2017: 32 services
| Critical care, each additional 30 minutes | 210 | $153,231 | $102 |
| Critical care, first 30-74 minutes | 243 | $106,963 | $222 |
| Return visit (30+ min) | 314 | $80,469 | $86 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 162 | $50,748 | $173 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 76 | $46,698 | $243 |
| New patient visit (45+ min) | 248 | $30,693 | $124 |
| Ct scan of abdomen and pelvis before and after contrast | 34 | $13,113 | $336 |
| Ct scan of chest before and after contrast | 42 | $11,262 | $262 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 178 | $10,481 | None |
| Complete ultrasound scan behind abdominal cavity | 32 | $5,733 | $106 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 13 | $5,381 | $414 |
| Short return visit (20+ min) | 17 | $4,338 | $63 |
| Ct scan head or brain without contrast | 34 | $3,915 | $109 |
| Injection of drug or substance under skin or into muscle | 54 | $3,399 | $23 |
| Complicated drainage of external ear abscess or blood accumulation | 16 | $3,337 | $209 |
| Application of lower and upper arm splint | 24 | $1,911 | $80 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 17 | $1,767 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 77 | $1,409 | $15 |
| Administration of influenza virus vaccine | 33 | $1,066 | $32 |
| Application of long leg splint from thigh to ankle or toe | 13 | $1,008 | $78 |
| Injection, ceftriaxone sodium, per 250 mg | 157 | $1,000 | None |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 72 | $948 | $12 |
| Urinalysis for bacteria | 100 | $756 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 37 | $698 | $19 |
| X-ray of wrist, 2 views | 16 | $549 | $27 |
| X-ray of hand, minimum of 3 views | 14 | $466 | $29 |
| Examination of eye by ophthalmoscope with retinal drawing | 19 | $417 | $22 |
| Injection, ketorolac tromethamine, per 15 mg | 38 | $390 | None |
| Blood test, comprehensive group of blood chemicals | 19 | $318 | $13 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 123 | $149 | None |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 21 | $99 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 28 | $44 | None |
2016: 39 services
| Critical care, each additional 30 minutes | 232 | $262,342 | $105 |
| Critical care, first 30-74 minutes | 275 | $147,132 | $233 |
| Return visit (30+ min) | 301 | $87,273 | $92 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 196 | $74,289 | $193 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 75 | $58,596 | $249 |
| New patient visit (45+ min) | 262 | $34,638 | $132 |
| Ct scan of abdomen and pelvis before and after contrast | 53 | $20,254 | $343 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 29 | $13,044 | $435 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 191 | $11,218 | None |
| Ct scan of chest before and after contrast | 26 | $7,143 | $265 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, each additional 5.0 cm or less | 19 | $6,939 | $154 |
| Injection of drug or substance under skin or into muscle | 86 | $6,621 | $24 |
| Complete ultrasound scan behind abdominal cavity | 40 | $6,447 | $109 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 13 | $5,536 | None |
| Short return visit (20+ min) | 23 | $4,446 | $64 |
| Fluoroscopic guidance for needle placement | 13 | $3,785 | $90 |
| Ct scan head or brain without contrast | 30 | $3,599 | $109 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 143 | $2,975 | $15 |
| Complicated drainage of external ear abscess or blood accumulation | 11 | $2,912 | $243 |
| X-ray of chest, minimum of 4 views | 54 | $2,730 | $40 |
| Injection, ceftriaxone sodium, per 250 mg | 200 | $1,787 | None |
| Application of lower and upper arm splint | 19 | $1,554 | $78 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 11 | $1,334 | $89 |
| Application of long leg splint from thigh to ankle or toe | 15 | $1,266 | $79 |
| Blood test, comprehensive group of blood chemicals | 64 | $1,201 | $13 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 23 | $1,124 | $47 |
| Administration of influenza virus vaccine | 30 | $950 | $32 |
| Urinalysis for bacteria | 110 | $858 | $3 |
| Injection, ketorolac tromethamine, per 15 mg | 57 | $611 | None |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 38 | $604 | $16 |
| X-ray of ankle, minimum of 3 views | 13 | $419 | $30 |
| X-ray of foot, minimum of 3 views | 13 | $388 | $28 |
| Examination of eye by ophthalmoscope with retinal drawing | 12 | $296 | $25 |
| Red blood cell concentration measurement | 49 | $241 | $3 |
| Blood count, hemoglobin | 40 | $203 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 39 | $189 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 111 | $183 | None |
| Creatine kinase (cardiac enzyme) level, total | 22 | $138 | $6 |
| Injection, ondansetron hydrochloride, per 1 mg | 35 | $47 | None |
2015: 38 services
| Critical care, each additional 30 minutes | 243 | $268,592 | $105 |
| Critical care, first 30-74 minutes | 296 | $136,800 | $235 |
| Return visit (30+ min) | 227 | $62,890 | $93 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 174 | $61,540 | $198 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 78 | $54,446 | $252 |
| New patient visit (45+ min) | 198 | $25,399 | $128 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 31 | $13,663 | $441 |
| Ct scan of abdomen and pelvis before and after contrast | 20 | $8,627 | $345 |
| Complete ultrasound scan behind abdominal cavity | 48 | $7,358 | $110 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, each additional 5.0 cm or less | 16 | $6,510 | $155 |
| Short return visit (20+ min) | 43 | $6,336 | $66 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 158 | $6,004 | None |
| X-ray of chest, minimum of 4 views | 87 | $5,118 | $40 |
| Injection of drug or substance under skin or into muscle | 73 | $4,453 | $24 |
| Complicated drainage of external ear abscess or blood accumulation | 14 | $3,312 | $237 |
| Immunologic analysis for detection of tumor antigen, qualitative or semiquantitative | 72 | $2,882 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 113 | $2,754 | $15 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 16 | $2,458 | $91 |
| Blood test, comprehensive group of blood chemicals | 89 | $1,757 | $13 |
| Injection, ceftriaxone sodium, per 250 mg | 169 | $1,730 | None |
| X-ray of hand, minimum of 3 views | 20 | $734 | $29 |
| Urinalysis for bacteria | 118 | $719 | $3 |
| X-ray of ankle, minimum of 3 views | 19 | $677 | $29 |
| X-ray of foot, minimum of 3 views | 18 | $669 | $28 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 13 | $608 | $47 |
| X-ray of knee, 4 or more views | 13 | $499 | $38 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 34 | $463 | $14 |
| Injection, ketorolac tromethamine, per 15 mg | 46 | $437 | None |
| X-ray of wrist, 2 views | 13 | $421 | $28 |
| Hemoglobin a1c level | 17 | $363 | $13 |
| Red blood cell concentration measurement | 77 | $352 | $3 |
| Examination of eye by ophthalmoscope with retinal drawing | 14 | $348 | $25 |
| Blood count, hemoglobin | 65 | $308 | $3 |
| Creatine kinase (cardiac enzyme) level, total | 30 | $183 | $6 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 54 | $89 | None |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 11 | $38 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 44 | $33 | None |
| Injection, ondansetron hydrochloride, per 1 mg | 26 | $26 | None |
2014: 43 services
| Critical care, each additional 30 minutes | 192 | $173,787 | $107 |
| Critical care, first 30-74 minutes | 228 | $91,744 | $238 |
| Infusion into tissue for therapy or prevention, 1 hour or less | 113 | $40,267 | $198 |
| Return visit (30+ min) | 123 | $37,934 | $94 |
| Removal of foreign body from tissue, accessed beneath the skin, complex | 45 | $28,786 | $255 |
| Complete ultrasound scan behind abdominal cavity | 76 | $27,672 | $132 |
| New patient visit (45+ min) | 146 | $18,653 | $128 |
| Short return visit (20+ min) | 54 | $5,972 | $66 |
| Complicated drainage of abscess in finger | 13 | $4,916 | $378 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $3,904 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 75 | $3,242 | $16 |
| Immunologic analysis for detection of tumor antigen, qualitative or semiquantitative | 58 | $2,567 | $25 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 17 | $1,662 | $66 |
| X-ray of chest, minimum of 4 views | 26 | $1,382 | $46 |
| Ultrasonic guidance for needle placement | 12 | $1,128 | $70 |
| Application of lower and upper arm splint | 13 | $1,074 | $77 |
| Complete ultrasound scan of pelvis | 11 | $972 | $69 |
| Inhalation treatment for acute airway obstruction, first hour | 18 | $949 | $45 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 14 | $884 | $18 |
| X-ray of hand, minimum of 3 views | 20 | $694 | $33 |
| Pulmonary exercise testing | 11 | $682 | $52 |
| Blood test, comprehensive group of blood chemicals | 51 | $666 | $10 |
| Natriuretic peptide (heart and blood vessel protein) level | 14 | $635 | $45 |
| Examination of eye by ophthalmoscope with retinal drawing | 22 | $584 | $24 |
| X-ray of foot, minimum of 3 views | 13 | $505 | $32 |
| X-ray of wrist, 2 views | 13 | $498 | $31 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 31 | $481 | None |
| X-ray of ankle, minimum of 3 views | 11 | $439 | $34 |
| Injection, morphine sulfate, up to 10 mg | 32 | $435 | None |
| Urinalysis for bacteria | 63 | $401 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 28 | $397 | $14 |
| Platelet aggregation function test | 11 | $345 | $29 |
| Injection, ceftriaxone sodium, per 250 mg | 53 | $343 | None |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 18 | $273 | $12 |
| Hemoglobin a1c level | 16 | $234 | $13 |
| Injection, tobramycin sulfate, up to 80 mg | 16 | $229 | None |
| Calcium level, ionized | 16 | $146 | $8 |
| Creatine kinase (cardiac enzyme) level, total | 23 | $139 | $6 |
| Red blood cell concentration measurement | 16 | $54 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 11 | $47 | None |
| Blood count, hemoglobin | 14 | $44 | $3 |
| Injection, ondansetron hydrochloride, per 1 mg | 15 | $7 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13 | $5 | None |
2013: 13 services
| Complete ultrasound scan behind abdominal cavity | 49 | $25,566 | $135 |
| Return visit (30+ min) | 65 | $23,858 | $95 |
| Complex measurement of pressure of urine flow in bladder | 29 | $12,281 | $267 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 15 | $10,755 | $336 |
| Ultrasound scan of prostate through rectum | 18 | $5,095 | $170 |
| Limited ultrasound scan behind abdominal cavity | 16 | $5,021 | $112 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 53 | $4,558 | $18 |
| Short return visit (20+ min) | 25 | $3,555 | $63 |
| Pulmonary exercise testing | 25 | $1,768 | $54 |
| Inhalation treatment for acute airway obstruction, first hour | 18 | $954 | $45 |
| Test to measure expiratory airflow and volume | 18 | $761 | $38 |
| Urinalysis, manual test | 39 | $497 | $3 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 12 | $146 | $12 |
Drugs they prescribed that Part D paid
$164,610
Pharmacies billed $164,610 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (31 of 2,466) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
2,226 generic and 226 brand-name prescriptions · $164,610 in drug cost · 264 antibiotic prescriptions to 134 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 24 | $34,730 | $1,447 |
| Jardiance | 20 | $20,362 | $1,018 |
| Prolia | 11 | $18,825 | $1,711 |
| Xarelto | 14 | $17,075 | $1,220 |
| Ozempic | 16 | $14,983 | $936 |
See all 64 drugs
| Eliquis | 24 | $34,730 | $1,447 |
| Jardiance | 20 | $20,362 | $1,018 |
| Prolia | 11 | $18,825 | $1,711 |
| Xarelto | 14 | $17,075 | $1,220 |
| Ozempic | 16 | $14,983 | $936 |
| Buprenorphine-Naloxone | 44 | $3,571 | $81 |
| Celecoxib | 50 | $3,211 | $64 |
| Gabapentin | 128 | $1,286 | $10 |
| Rosuvastatin | 60 | $1,187 | $20 |
| Levothyroxine | 123 | $1,143 | $9 |
| Omeprazole | 65 | $987 | $15 |
| Atorvastatin | 155 | $852 | $5 |
| Fenofibrate | 36 | $678 | $19 |
| Metoprolol | 43 | $570 | $13 |
| Metformin | 78 | $511 | $7 |
| Fluoxetine | 66 | $464 | $7 |
| Tamsulosin | 32 | $459 | $14 |
| Alendronate | 58 | $455 | $8 |
| Lisinopril | 67 | $426 | $6 |
| Losartan | 41 | $423 | $10 |
| Nitrofurantoin Mono-Macro | 36 | $395 | $11 |
| Albuterol Sulfate Hfa | 16 | $385 | $24 |
| Amlodipine Besylate | 53 | $356 | $7 |
| Duloxetine | 24 | $315 | $13 |
| Allopurinol | 17 | $306 | $18 |
| Olmesartan Medoxomil | 13 | $255 | $20 |
| Potassium Citrate Er | 11 | $245 | $22 |
| Pravastatin | 23 | $217 | $9 |
| Azithromycin | 58 | $217 | $4 |
| Clonidine | 15 | $202 | $13 |
| Cephalexin | 34 | $202 | $6 |
| Cefdinir | 21 | $200 | $10 |
| Sertraline | 59 | $192 | $3 |
| Mupirocin | 27 | $190 | $7 |
| Paroxetine | 22 | $167 | $8 |
| Amoxicillin-Clavulanate Potass | 32 | $166 | $5 |
| Furosemide | 36 | $166 | $5 |
| Donepezil | 13 | $164 | $13 |
| Hydrochlorothiazide | 24 | $155 | $6 |
| Triamcinolone Acetonide | 37 | $154 | $4 |
| Clarithromycin | 11 | $153 | $14 |
| Alprazolam | 25 | $128 | $5 |
| Lamotrigine | 12 | $116 | $10 |
| Hydrocodone-Acetaminophen | 19 | $113 | $6 |
| Ketoconazole | 13 | $110 | $8 |
| Ciprofloxacin | 27 | $108 | $4 |
| Atenolol | 14 | $106 | $8 |
| Propranolol Hcl Er | 11 | $96 | $9 |
| Baclofen | 11 | $91 | $8 |
| Doxepin | 12 | $87 | $7 |
| Pioglitazone | 11 | $73 | $7 |
| Trazodone | 14 | $66 | $5 |
| Zolpidem | 11 | $64 | $6 |
| Sulfamethoxazole-Trimethoprim | 31 | $61 | $2 |
| Ondansetron | 11 | $59 | $5 |
| Glipizide | 25 | $44 | $2 |
| Acyclovir | 16 | $39 | $2 |
| Amoxicillin | 11 | $38 | $3 |
| Venlafaxine Hcl Er | 12 | $35 | $3 |
| Metoprolol | 16 | $29 | $2 |
| Simvastatin | 15 | $27 | $2 |
| Meclizine | 14 | $23 | $2 |
| Prednisone | 11 | $20 | $2 |
| Paxlovid | 16 | $0 | $0 |
Year by year
| 2024 | 2,466 | 224 | 1% (31) | 9% | $164,610 |
| 2023 | 2,220 | 218 | 1% (23) | 10% | $147,490 |
| 2022 | 2,002 | 211 | 1% (20) | 9% | $115,900 |
| 2021 | 1,812 | 201 | 2% (27) | None | $71,563 |
| 2020 | 1,884 | 200 | 2% (31) | None | $88,530 |
| 2019 | 2,017 | 270 | 3% (55) | None | $92,804 |
| 2018 | 2,215 | 307 | 3% (69) | None | $100,325 |
| 2017 | 2,084 | 315 | 3% (60) | None | $97,275 |
| 2016 | 1,818 | 285 | 3% (61) | None | $74,973 |
| 2015 | 1,453 | 222 | 4% (60) | None | $64,599 |
| 2014 | 1,126 | 178 | 5% (59) | None | $48,301 |
| 2013 | 879 | 57 | 3% (24) | None | $46,284 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 61 drugs
| Eliquis | 22 | $29,488 | $1,340 |
| Celecoxib | 41 | $3,822 | $93 |
| Suboxone | 11 | $2,972 | $270 |
| Buprenorphine-Naloxone | 29 | $2,844 | $98 |
| Gabapentin | 108 | $2,053 | $19 |
| Atorvastatin | 138 | $1,701 | $12 |
| Sucralfate | 11 | $1,684 | $153 |
| Levothyroxine | 116 | $1,617 | $14 |
| Omeprazole | 52 | $1,534 | $30 |
| Pioglitazone | 12 | $1,100 | $92 |
| Ventolin Hfa | 14 | $868 | $62 |
| Amlodipine Besylate | 59 | $839 | $14 |
| Lisinopril | 59 | $788 | $13 |
| Valacyclovir | 14 | $739 | $53 |
| Fenofibrate | 23 | $728 | $32 |
| Metformin | 52 | $687 | $13 |
| Tamsulosin | 21 | $686 | $33 |
| Albuterol Sulfate Hfa | 19 | $675 | $36 |
| Olmesartan Medoxomil | 18 | $672 | $37 |
| Alendronate | 33 | $671 | $20 |
| Pravastatin | 12 | $573 | $48 |
| Metoprolol | 20 | $537 | $27 |
| Fluoxetine | 59 | $521 | $9 |
| Losartan | 26 | $462 | $18 |
| Sertraline | 30 | $460 | $15 |
| Rosuvastatin | 19 | $436 | $23 |
| Atenolol | 27 | $418 | $15 |
| Ketoconazole | 16 | $383 | $24 |
| Donepezil | 12 | $377 | $31 |
| Escitalopram | 21 | $374 | $18 |
| Furosemide | 45 | $354 | $8 |
| Cephalexin | 32 | $336 | $11 |
| Ropinirole | 12 | $301 | $25 |
| Azithromycin | 52 | $294 | $6 |
| Nitrofurantoin Mono-Macro | 22 | $291 | $13 |
| Cefdinir | 12 | $280 | $23 |
| Allopurinol | 17 | $255 | $15 |
| Ciprofloxacin | 26 | $254 | $10 |
| Duloxetine | 24 | $251 | $10 |
| Triamcinolone Acetonide | 36 | $246 | $7 |
| Glipizide | 14 | $240 | $17 |
| Mupirocin | 22 | $236 | $11 |
| Clonidine | 12 | $231 | $19 |
| Alprazolam | 31 | $229 | $7 |
| Sulfamethoxazole-Trimethoprim | 39 | $223 | $6 |
| Paxlovid (Eua) | 20 | $208 | $10 |
| Methylprednisolone | 21 | $207 | $10 |
| Paroxetine | 13 | $192 | $15 |
| Doxazosin Mesylate | 14 | $186 | $13 |
| Clarithromycin | 12 | $182 | $15 |
| Trazodone | 24 | $182 | $8 |
| Amoxicillin-Clavulanate Potass | 20 | $174 | $9 |
| Hydrochlorothiazide | 29 | $131 | $5 |
| Metoprolol | 18 | $128 | $7 |
| Simvastatin | 16 | $123 | $8 |
| Spironolactone | 16 | $109 | $7 |
| Doxepin | 11 | $95 | $9 |
| Phenobarbital | 11 | $80 | $7 |
| Baclofen | 14 | $70 | $5 |
| Clonazepam | 11 | $50 | $5 |
| Hydroxyzine Pamoate | 15 | $46 | $3 |
2022: 59 drugs
| Eliquis | 16 | $20,568 | $1,286 |
| Buprenorphine-Naloxone | 36 | $4,963 | $138 |
| Amiodarone | 12 | $3,112 | $259 |
| Gabapentin | 96 | $1,879 | $20 |
| Duloxetine | 19 | $1,738 | $91 |
| Celecoxib | 21 | $1,503 | $72 |
| Levothyroxine | 82 | $1,303 | $16 |
| Omeprazole | 64 | $1,281 | $20 |
| Atorvastatin | 108 | $1,235 | $11 |
| Nitrofurantoin Mono-Macro | 36 | $1,197 | $33 |
| Cyclobenzaprine | 15 | $994 | $66 |
| Albuterol Sulfate Hfa | 26 | $953 | $37 |
| Ketoconazole | 15 | $837 | $56 |
| Memantine | 14 | $796 | $57 |
| Fenofibrate | 15 | $599 | $40 |
| Alendronate | 47 | $552 | $12 |
| Propranolol | 11 | $529 | $48 |
| Metoprolol | 22 | $470 | $21 |
| Donepezil | 14 | $433 | $31 |
| Lisinopril | 47 | $361 | $8 |
| Losartan | 37 | $357 | $10 |
| Escitalopram | 19 | $331 | $17 |
| Pravastatin | 12 | $313 | $26 |
| Allopurinol | 21 | $307 | $15 |
| Fluoxetine | 26 | $303 | $12 |
| Valacyclovir | 12 | $293 | $24 |
| Metformin | 47 | $289 | $6 |
| Tamsulosin | 15 | $250 | $17 |
| Cephalexin | 31 | $241 | $8 |
| Azithromycin | 38 | $238 | $6 |
| Triamcinolone Acetonide | 50 | $221 | $4 |
| Ropinirole | 12 | $219 | $18 |
| Amoxicillin-Clavulanate Potass | 29 | $219 | $8 |
| Pioglitazone | 14 | $218 | $16 |
| Amlodipine Besylate | 41 | $192 | $5 |
| Fluticasone Propionate | 14 | $186 | $13 |
| Clopidogrel | 11 | $185 | $17 |
| Mupirocin | 28 | $183 | $7 |
| Montelukast | 11 | $178 | $16 |
| Paxlovid (Eua) | 15 | $159 | $11 |
| Paroxetine | 13 | $159 | $12 |
| Methylprednisolone | 17 | $143 | $8 |
| Alprazolam | 32 | $138 | $4 |
| Ciprofloxacin | 25 | $134 | $5 |
| Sertraline | 15 | $130 | $9 |
| Sulfamethoxazole-Trimethoprim | 36 | $130 | $4 |
| Hydrocodone-Acetaminophen | 13 | $126 | $10 |
| Hydrochlorothiazide | 26 | $124 | $5 |
| Doxazosin Mesylate | 14 | $116 | $8 |
| Metoprolol | 21 | $101 | $5 |
| Clonazepam | 12 | $86 | $7 |
| Baclofen | 13 | $72 | $6 |
| Meclizine | 16 | $72 | $4 |
| Hydroxyzine Pamoate | 13 | $61 | $5 |
| Furosemide | 16 | $60 | $4 |
| Lorazepam | 15 | $46 | $3 |
| Simvastatin | 17 | $38 | $2 |
| Atenolol | 19 | $29 | $2 |
| Prednisone | 11 | $27 | $2 |
2021: 57 drugs
| Buprenorphine-Naloxone | 35 | $4,747 | $136 |
| Gabapentin | 87 | $1,794 | $21 |
| Nitrofurantoin Mono-Macro | 26 | $1,444 | $56 |
| Levothyroxine | 71 | $1,391 | $20 |
| Omeprazole | 75 | $1,355 | $18 |
| Celecoxib | 23 | $1,345 | $58 |
| Atorvastatin | 109 | $1,239 | $11 |
| Albuterol Sulfate Hfa | 19 | $934 | $49 |
| Neomycin-Polymyxin-Hydrocort | 14 | $798 | $57 |
| Nitroglycerin | 12 | $735 | $61 |
| Hydroxychloroquine Sulfate | 15 | $707 | $47 |
| Ketoconazole | 11 | $607 | $55 |
| Fenofibrate | 14 | $574 | $41 |
| Cyclobenzaprine | 24 | $539 | $22 |
| Alendronate | 46 | $533 | $12 |
| Propranolol | 11 | $506 | $46 |
| Fenofibrate | 17 | $498 | $29 |
| Fluoxetine | 27 | $488 | $18 |
| Losartan | 39 | $479 | $12 |
| Rosuvastatin | 12 | $436 | $36 |
| Tamsulosin | 25 | $402 | $16 |
| Cephalexin | 40 | $374 | $9 |
| Diclofenac | 17 | $350 | $21 |
| Donepezil | 17 | $338 | $20 |
| Pioglitazone | 24 | $335 | $14 |
| Escitalopram | 26 | $327 | $13 |
| Duloxetine | 11 | $318 | $29 |
| Glipizide Er | 15 | $273 | $18 |
| Sulfamethoxazole-Trimethoprim | 54 | $259 | $5 |
| Pravastatin | 19 | $259 | $14 |
| Allopurinol | 20 | $254 | $13 |
| Metformin | 50 | $220 | $4 |
| Lisinopril | 40 | $209 | $5 |
| Dicyclomine | 16 | $208 | $13 |
| Simvastatin | 16 | $206 | $13 |
| Azithromycin | 21 | $202 | $10 |
| Hydrocodone-Acetaminophen | 18 | $178 | $10 |
| Mupirocin | 21 | $169 | $8 |
| Methylprednisolone | 16 | $167 | $10 |
| Clonidine | 14 | $167 | $12 |
| Amlodipine Besylate | 23 | $133 | $6 |
| Triamcinolone Acetonide | 28 | $130 | $5 |
| Meclizine | 20 | $122 | $6 |
| Zolpidem | 14 | $119 | $8 |
| Ciprofloxacin | 20 | $118 | $6 |
| Ropinirole | 12 | $106 | $9 |
| Amoxicillin-Clavulanate Potass | 15 | $105 | $7 |
| Hydrochlorothiazide | 22 | $105 | $5 |
| Atenolol | 18 | $100 | $6 |
| Alprazolam | 17 | $97 | $6 |
| Metoprolol | 21 | $94 | $4 |
| Hydroxyzine | 12 | $87 | $7 |
| Clonazepam | 12 | $86 | $7 |
| Tizanidine | 14 | $64 | $5 |
| Ibuprofen | 16 | $62 | $4 |
| Furosemide | 14 | $60 | $4 |
| Lorazepam | 12 | $58 | $5 |
2020: 59 drugs
| Eliquis | 13 | $13,116 | $1,009 |
| Buprenorphine-Naloxone | 40 | $6,720 | $168 |
| Hydroxychloroquine Sulfate | 14 | $2,265 | $162 |
| Ventolin Hfa | 25 | $1,497 | $60 |
| Bupropion Xl | 11 | $1,342 | $122 |
| Levothyroxine | 72 | $1,340 | $19 |
| Omeprazole | 81 | $1,301 | $16 |
| Atorvastatin | 104 | $1,266 | $12 |
| Nitrofurantoin Mono-Macro | 27 | $1,107 | $41 |
| Gabapentin | 89 | $1,011 | $11 |
| Fenofibrate | 17 | $885 | $52 |
| Diclofenac | 31 | $866 | $28 |
| Clarithromycin | 22 | $694 | $32 |
| Fenofibrate | 23 | $667 | $29 |
| Albuterol Sulfate Hfa | 13 | $552 | $42 |
| Metformin | 58 | $469 | $8 |
| Losartan | 39 | $439 | $11 |
| Duloxetine | 13 | $433 | $33 |
| Doxazosin Mesylate | 18 | $428 | $24 |
| Tamsulosin | 24 | $373 | $16 |
| Alendronate | 25 | $352 | $14 |
| Cyclobenzaprine | 30 | $341 | $11 |
| Glipizide Er | 16 | $290 | $18 |
| Escitalopram | 26 | $288 | $11 |
| Fluoxetine | 25 | $265 | $11 |
| Metoprolol | 12 | $264 | $22 |
| Lisinopril | 46 | $248 | $5 |
| Amoxicillin-Clavulanate Potass | 31 | $248 | $8 |
| Amlodipine Besylate | 46 | $242 | $5 |
| Dicyclomine | 12 | $223 | $19 |
| Cephalexin | 38 | $218 | $6 |
| Atenolol | 25 | $205 | $8 |
| Pravastatin | 12 | $203 | $17 |
| Sertraline | 15 | $200 | $13 |
| Pioglitazone | 13 | $187 | $14 |
| Alprazolam | 21 | $177 | $8 |
| Donepezil | 11 | $173 | $16 |
| Levofloxacin | 18 | $160 | $9 |
| Azithromycin | 24 | $142 | $6 |
| Paroxetine | 11 | $142 | $13 |
| Simvastatin | 18 | $135 | $8 |
| Triamterene-Hydrochlorothiazid | 12 | $133 | $11 |
| Sulfamethoxazole-Trimethoprim | 35 | $129 | $4 |
| Hydrocodone-Acetaminophen | 21 | $126 | $6 |
| Hydrochlorothiazide | 23 | $122 | $5 |
| Furosemide | 19 | $102 | $5 |
| Hydrocortisone | 17 | $101 | $6 |
| Ibuprofen | 17 | $99 | $6 |
| Meclizine | 18 | $97 | $5 |
| Metoprolol | 20 | $96 | $5 |
| Clonazepam | 13 | $93 | $7 |
| Ciprofloxacin | 17 | $82 | $5 |
| Mupirocin | 12 | $80 | $7 |
| Trazodone | 12 | $77 | $6 |
| Glipizide | 14 | $72 | $5 |
| Diazepam | 19 | $63 | $3 |
| Lorazepam | 13 | $58 | $4 |
| Triamcinolone Acetonide | 12 | $48 | $4 |
| Zolpidem | 11 | $12 | $1 |
2019: 62 drugs
| Eliquis | 14 | $7,843 | $560 |
| Buprenorphine-Naloxone | 33 | $7,184 | $218 |
| Suboxone | 23 | $7,134 | $310 |
| Amiodarone | 11 | $2,188 | $199 |
| Levothyroxine | 101 | $1,470 | $15 |
| Ventolin Hfa | 24 | $1,378 | $57 |
| Clarithromycin | 52 | $1,280 | $25 |
| Atorvastatin | 79 | $1,101 | $14 |
| Gabapentin | 69 | $1,029 | $15 |
| Bupropion Xl | 16 | $1,022 | $64 |
| Neomycin-Polymyxin-Hydrocort | 16 | $1,002 | $63 |
| Omeprazole | 53 | $876 | $17 |
| Fenofibrate | 16 | $851 | $53 |
| Albuterol Sulfate Hfa | 16 | $751 | $47 |
| Levofloxacin | 41 | $584 | $14 |
| Nitrofurantoin Mono-Macro | 18 | $583 | $32 |
| Nitroglycerin | 11 | $498 | $45 |
| Lisinopril | 74 | $446 | $6 |
| Fenofibrate | 12 | $427 | $36 |
| Tamsulosin | 27 | $399 | $15 |
| Alendronate | 32 | $385 | $12 |
| Losartan | 34 | $380 | $11 |
| Cefdinir | 17 | $380 | $22 |
| Sumatriptan | 12 | $374 | $31 |
| Glipizide Er | 17 | $359 | $21 |
| Metformin | 57 | $359 | $6 |
| Azithromycin | 42 | $337 | $8 |
| Ofloxacin | 16 | $309 | $19 |
| Cephalexin | 36 | $306 | $8 |
| Doxazosin Mesylate | 14 | $285 | $20 |
| Methylprednisolone | 20 | $279 | $14 |
| Venlafaxine Hcl Er | 16 | $264 | $16 |
| Donepezil | 11 | $258 | $23 |
| Amlodipine Besylate | 45 | $245 | $5 |
| Fluoxetine | 24 | $238 | $10 |
| Hydrocodone-Acetaminophen | 30 | $221 | $7 |
| Mupirocin | 20 | $202 | $10 |
| Simvastatin | 33 | $200 | $6 |
| Sulfamethoxazole-Trimethoprim | 47 | $196 | $4 |
| Montelukast | 13 | $194 | $15 |
| Amoxicillin-Clavulanate Potass | 21 | $183 | $9 |
| Atenolol | 22 | $182 | $8 |
| Escitalopram | 13 | $176 | $14 |
| Triamterene-Hydrochlorothiazid | 17 | $168 | $10 |
| Hydroxyzine | 18 | $158 | $9 |
| Diclofenac | 12 | $154 | $13 |
| Allopurinol | 13 | $151 | $12 |
| Ciprofloxacin | 23 | $142 | $6 |
| Hydrochlorothiazide | 26 | $141 | $5 |
| Meclizine | 12 | $132 | $11 |
| Glipizide | 17 | $127 | $7 |
| Dicyclomine | 11 | $126 | $11 |
| Cyclobenzaprine | 22 | $118 | $5 |
| Ondansetron | 12 | $105 | $9 |
| Alprazolam | 30 | $105 | $3 |
| Sertraline | 16 | $104 | $6 |
| Furosemide | 15 | $94 | $6 |
| Clonazepam | 13 | $84 | $6 |
| Metoprolol | 16 | $66 | $4 |
| Oxycodone-Acetaminophen | 13 | $60 | $5 |
| Triamcinolone Acetonide | 13 | $56 | $4 |
| Diazepam | 13 | $26 | $2 |
2018: 57 drugs
| Suboxone | 38 | $10,597 | $279 |
| Ventolin Hfa | 34 | $2,007 | $59 |
| Proair Hfa | 22 | $1,367 | $62 |
| Levothyroxine | 85 | $1,312 | $15 |
| Celecoxib | 14 | $1,295 | $92 |
| Fenofibrate | 20 | $1,151 | $58 |
| Clarithromycin | 43 | $1,059 | $25 |
| Atorvastatin | 73 | $1,002 | $14 |
| Neomycin-Polymyxin-Hydrocort | 19 | $978 | $51 |
| Venlafaxine Hcl Er | 25 | $971 | $39 |
| Methylprednisolone | 74 | $868 | $12 |
| Omeprazole | 56 | $867 | $15 |
| Doxazosin Mesylate | 22 | $749 | $34 |
| Nitrofurantoin Mono-Macro | 26 | $749 | $29 |
| Tamsulosin | 38 | $648 | $17 |
| Nifedipine Er | 11 | $535 | $49 |
| Azithromycin | 78 | $532 | $7 |
| Hydrocodone-Acetaminophen | 52 | $516 | $10 |
| Metformin | 57 | $441 | $8 |
| Gabapentin | 61 | $423 | $7 |
| Levofloxacin | 50 | $371 | $7 |
| Bupropion Xl | 16 | $366 | $23 |
| Lisinopril | 71 | $330 | $5 |
| Amlodipine Besylate | 47 | $311 | $7 |
| Cephalexin | 37 | $307 | $8 |
| Amoxicillin-Clavulanate Potass | 37 | $297 | $8 |
| Fenofibrate | 12 | $295 | $25 |
| Valsartan-Hydrochlorothiazide | 11 | $283 | $26 |
| Donepezil | 21 | $269 | $13 |
| Losartan | 33 | $243 | $7 |
| Meclizine | 24 | $228 | $9 |
| Cefdinir | 13 | $226 | $17 |
| Alendronate | 21 | $197 | $9 |
| Sulfamethoxazole-Trimethoprim | 46 | $186 | $4 |
| Allopurinol | 15 | $185 | $12 |
| Zolpidem | 24 | $142 | $6 |
| Atenolol | 19 | $133 | $7 |
| Hydrochlorothiazide | 24 | $122 | $5 |
| Hydroxyzine | 16 | $122 | $8 |
| Mupirocin | 16 | $121 | $8 |
| Dicyclomine | 14 | $118 | $8 |
| Glipizide | 31 | $112 | $4 |
| Fluoxetine | 32 | $111 | $3 |
| Cyclobenzaprine | 13 | $103 | $8 |
| Furosemide | 31 | $100 | $3 |
| Triamterene-Hydrochlorothiazid | 20 | $98 | $5 |
| Ciprofloxacin | 20 | $98 | $5 |
| Lorazepam | 21 | $93 | $4 |
| Ranitidine | 12 | $80 | $7 |
| Metoprolol | 19 | $78 | $4 |
| Ibuprofen | 19 | $78 | $4 |
| Hydrocortisone | 13 | $78 | $6 |
| Clonazepam | 13 | $73 | $6 |
| Alprazolam | 14 | $69 | $5 |
| Prednisone | 22 | $67 | $3 |
| Triamcinolone Acetonide | 12 | $60 | $5 |
| Simvastatin | 26 | $56 | $2 |
2017: 63 drugs
| Suboxone | 41 | $10,750 | $262 |
| Xarelto | 15 | $9,699 | $647 |
| Celecoxib | 24 | $2,197 | $92 |
| Proair Hfa | 25 | $1,537 | $61 |
| Ventolin Hfa | 28 | $1,491 | $53 |
| Levothyroxine | 61 | $1,119 | $18 |
| Fenofibrate | 18 | $793 | $44 |
| Doxazosin Mesylate | 17 | $773 | $45 |
| Methylprednisolone | 62 | $766 | $12 |
| Neomycin-Polymyxin-Hydrocort | 14 | $715 | $51 |
| Atorvastatin | 52 | $704 | $14 |
| Neomycin-Polymyxin-Hc | 11 | $616 | $56 |
| Tamsulosin | 31 | $586 | $19 |
| Gabapentin | 69 | $533 | $8 |
| Omeprazole | 40 | $532 | $13 |
| Levofloxacin | 39 | $511 | $13 |
| Hydrocodone-Acetaminophen | 49 | $503 | $10 |
| Azithromycin | 71 | $500 | $7 |
| Amoxicillin-Clavulanate Potass | 55 | $483 | $9 |
| Clarithromycin | 17 | $453 | $27 |
| Bupropion Xl | 15 | $410 | $27 |
| Cefdinir | 18 | $366 | $20 |
| Lisinopril | 60 | $308 | $5 |
| Ciprofloxacin | 42 | $290 | $7 |
| Metformin | 46 | $277 | $6 |
| Amlodipine Besylate | 56 | $277 | $5 |
| Valsartan-Hydrochlorothiazide | 11 | $263 | $24 |
| Ofloxacin | 14 | $248 | $18 |
| Sulfamethoxazole-Trimethoprim | 47 | $243 | $5 |
| Isosorbide Mononitrate Er | 12 | $218 | $18 |
| Allopurinol | 15 | $215 | $14 |
| Dilt-Xr | 11 | $214 | $19 |
| Hydrocortisone | 19 | $203 | $11 |
| Losartan | 27 | $194 | $7 |
| Paroxetine | 13 | $190 | $15 |
| Donepezil | 22 | $190 | $9 |
| Cephalexin | 30 | $164 | $5 |
| Escitalopram | 11 | $163 | $15 |
| Alendronate | 19 | $156 | $8 |
| Mupirocin | 19 | $152 | $8 |
| Fluticasone Propionate | 13 | $146 | $11 |
| Triamterene-Hydrochlorothiazid | 22 | $142 | $6 |
| Quetiapine | 15 | $132 | $9 |
| Ranitidine | 16 | $130 | $8 |
| Meclizine | 17 | $128 | $8 |
| Lorazepam | 34 | $127 | $4 |
| Simvastatin | 33 | $122 | $4 |
| Levetiracetam | 12 | $117 | $10 |
| Glyburide | 12 | $110 | $9 |
| Ropinirole | 11 | $109 | $10 |
| Atenolol | 21 | $104 | $5 |
| Glipizide | 20 | $95 | $5 |
| Metoprolol | 23 | $94 | $4 |
| Furosemide | 29 | $92 | $3 |
| Amoxicillin | 15 | $88 | $6 |
| Zolpidem | 24 | $87 | $4 |
| Venlafaxine Hcl Er | 12 | $86 | $7 |
| Clonazepam | 13 | $71 | $5 |
| Ibuprofen | 14 | $68 | $5 |
| Fluoxetine | 19 | $66 | $3 |
| Sertraline | 13 | $55 | $4 |
| Prednisone | 17 | $54 | $3 |
| Hydrochlorothiazide | 17 | $42 | $2 |
2016: 58 drugs
| Prolia | 13 | $13,186 | $1,014 |
| Suboxone | 34 | $10,621 | $312 |
| Atrovent Hfa | 13 | $3,877 | $298 |
| Celecoxib | 39 | $2,812 | $72 |
| Tolterodine Tartrate Er | 12 | $1,822 | $152 |
| Buprenorphine | 15 | $1,587 | $106 |
| Memantine | 16 | $988 | $62 |
| Levothyroxine | 50 | $856 | $17 |
| Proair Hfa | 12 | $752 | $63 |
| Doxazosin Mesylate | 12 | $693 | $58 |
| Neomycin-Polymyxin-Hc | 16 | $656 | $41 |
| Atorvastatin | 40 | $595 | $15 |
| Amoxicillin-Clavulanate Potass | 58 | $593 | $10 |
| Tamsulosin | 37 | $563 | $15 |
| Bupropion Xl | 22 | $530 | $24 |
| Methylprednisolone | 29 | $498 | $17 |
| Levofloxacin | 41 | $488 | $12 |
| Quetiapine | 37 | $457 | $12 |
| Gabapentin | 69 | $423 | $6 |
| Hydrocodone-Acetaminophen | 38 | $381 | $10 |
| Valsartan-Hydrochlorothiazide | 11 | $368 | $33 |
| Clarithromycin | 11 | $364 | $33 |
| Cephalexin | 43 | $307 | $7 |
| Omeprazole | 34 | $303 | $9 |
| Ciprofloxacin | 40 | $298 | $7 |
| Nitrofurantoin Mono-Macro | 11 | $292 | $27 |
| Metformin | 51 | $287 | $6 |
| Azithromycin | 41 | $272 | $7 |
| Amlodipine Besylate | 45 | $259 | $6 |
| Allopurinol | 14 | $233 | $17 |
| Fluticasone Propionate | 20 | $215 | $11 |
| Meclizine | 21 | $202 | $10 |
| Triamterene-Hydrochlorothiazid | 26 | $196 | $8 |
| Lisinopril | 46 | $192 | $4 |
| Atenolol | 32 | $190 | $6 |
| Ondansetron Odt | 12 | $182 | $15 |
| Simvastatin | 31 | $170 | $5 |
| Montelukast | 15 | $169 | $11 |
| Sulfamethoxazole-Trimethoprim | 36 | $160 | $4 |
| Ranitidine | 17 | $147 | $9 |
| Isosorbide Mononitrate Er | 12 | $140 | $12 |
| Glipizide | 18 | $130 | $7 |
| Alendronate | 14 | $121 | $9 |
| Donepezil | 14 | $120 | $9 |
| Hydrochlorothiazide | 22 | $113 | $5 |
| Losartan | 13 | $107 | $8 |
| Zolpidem | 19 | $102 | $5 |
| Lorazepam | 24 | $102 | $4 |
| Clonazepam | 17 | $97 | $6 |
| Venlafaxine Hcl Er | 12 | $87 | $7 |
| Furosemide | 31 | $86 | $3 |
| Escitalopram | 15 | $79 | $5 |
| Fluoxetine | 21 | $75 | $4 |
| Prednisone | 23 | $73 | $3 |
| Metoprolol | 18 | $68 | $4 |
| Ropinirole | 11 | $59 | $5 |
| Tramadol | 11 | $53 | $5 |
| Sertraline | 11 | $33 | $3 |
2015: 46 drugs
| Suboxone | 27 | $5,639 | $209 |
| Celecoxib | 32 | $4,767 | $149 |
| Atrovent Hfa | 14 | $3,670 | $262 |
| Proair Hfa | 34 | $2,650 | $78 |
| Buprenorphine | 13 | $1,081 | $83 |
| Levothyroxine | 47 | $809 | $17 |
| Voltaren | 17 | $787 | $46 |
| Doxazosin Mesylate | 12 | $780 | $65 |
| Atorvastatin | 38 | $711 | $19 |
| Memantine | 12 | $665 | $55 |
| Tamsulosin | 26 | $661 | $25 |
| Gabapentin | 67 | $600 | $9 |
| Amoxicillin-Clavulanate Potass | 56 | $547 | $10 |
| Hydrocodone-Acetaminophen | 37 | $442 | $12 |
| Meclizine | 26 | $408 | $16 |
| Zolpidem | 34 | $403 | $12 |
| Nitrofurantoin Mono-Macro | 13 | $399 | $31 |
| Levofloxacin | 16 | $390 | $24 |
| Methylprednisolone | 17 | $338 | $20 |
| Omeprazole | 21 | $262 | $12 |
| Azithromycin | 39 | $260 | $7 |
| Ofloxacin | 14 | $238 | $17 |
| Hydrochlorothiazide | 34 | $214 | $6 |
| Simvastatin | 33 | $204 | $6 |
| Triamterene-Hydrochlorothiazid | 16 | $197 | $12 |
| Amlodipine Besylate | 39 | $197 | $5 |
| Fluticasone Propionate | 21 | $189 | $9 |
| Isosorbide Mononitrate Er | 13 | $183 | $14 |
| Ciprofloxacin | 33 | $180 | $5 |
| Atenolol | 26 | $166 | $6 |
| Ranitidine | 12 | $144 | $12 |
| Cephalexin | 26 | $140 | $5 |
| Prednisone | 31 | $140 | $5 |
| Metformin | 23 | $132 | $6 |
| Alendronate | 13 | $125 | $10 |
| Fluoxetine | 23 | $123 | $5 |
| Clonazepam | 13 | $107 | $8 |
| Carvedilol | 11 | $107 | $10 |
| Glipizide | 11 | $102 | $9 |
| Lisinopril | 19 | $96 | $5 |
| Sulfamethoxazole-Trimethoprim | 19 | $78 | $4 |
| Ibuprofen | 11 | $67 | $6 |
| Escitalopram | 11 | $62 | $6 |
| Hydrocortisone | 11 | $57 | $5 |
| Metoprolol | 14 | $51 | $4 |
| Lorazepam | 19 | $47 | $2 |
2014: 35 drugs
| Celebrex | 22 | $6,030 | $274 |
| Proair Hfa | 20 | $1,227 | $61 |
| Doxazosin Mesylate | 15 | $987 | $66 |
| Atorvastatin | 38 | $882 | $23 |
| Econazole Nitrate | 19 | $833 | $44 |
| Hydrocodone-Acetaminophen | 39 | $757 | $19 |
| Levothyroxine | 31 | $699 | $23 |
| Gabapentin | 48 | $614 | $13 |
| Amox Tr-Potassium Clavulanate | 46 | $569 | $12 |
| Omeprazole | 22 | $364 | $17 |
| Isosorbide Mononitrate Er | 12 | $336 | $28 |
| Fluticasone Propionate | 16 | $315 | $20 |
| Zolpidem | 31 | $314 | $10 |
| Tamsulosin | 12 | $287 | $24 |
| Triamterene-Hydrochlorothiazid | 12 | $257 | $21 |
| Azithromycin | 30 | $251 | $8 |
| Amlodipine Besylate | 37 | $249 | $7 |
| Neomycin-Polymyxin-Hydrocort | 11 | $229 | $21 |
| Fluoxetine | 25 | $221 | $9 |
| Amiodarone | 11 | $201 | $18 |
| Prednisone | 34 | $198 | $6 |
| Cephalexin | 25 | $177 | $7 |
| Sertraline | 18 | $176 | $10 |
| Metformin | 15 | $166 | $11 |
| Acetaminophen-Codeine | 13 | $150 | $12 |
| Glipizide | 17 | $140 | $8 |
| Ciprofloxacin | 24 | $134 | $6 |
| Simvastatin | 15 | $133 | $9 |
| Atenolol | 24 | $126 | $5 |
| Hydrochlorothiazide | 20 | $123 | $6 |
| Lisinopril | 15 | $118 | $8 |
| Metoprolol | 13 | $84 | $6 |
| Furosemide | 15 | $69 | $5 |
| Benazepril | 11 | $59 | $5 |
| Lorazepam | 12 | $59 | $5 |
2013: 32 drugs
| Celebrex | 34 | $9,609 | $283 |
| Nexium | 17 | $5,473 | $322 |
| Atorvastatin | 46 | $1,668 | $36 |
| Proair Hfa | 21 | $1,649 | $79 |
| Gabapentin | 45 | $675 | $15 |
| Nifedipine Er | 11 | $607 | $55 |
| Omeprazole | 18 | $491 | $27 |
| Fluoxetine | 30 | $490 | $16 |
| Clopidogrel | 16 | $472 | $30 |
| Econazole Nitrate | 14 | $422 | $30 |
| Amlodipine Besylate | 37 | $419 | $11 |
| Metformin | 34 | $401 | $12 |
| Glyburide | 16 | $401 | $25 |
| Doxazosin Mesylate | 16 | $400 | $25 |
| Levothyroxine | 21 | $368 | $18 |
| Glipizide | 24 | $276 | $11 |
| Isosorbide Mononitrate Er | 12 | $255 | $21 |
| Carvedilol | 13 | $247 | $19 |
| Simvastatin | 13 | $192 | $15 |
| Acetaminophen-Codeine | 15 | $155 | $10 |
| Lorazepam | 16 | $143 | $9 |
| Sertraline | 11 | $138 | $13 |
| Nortriptyline | 13 | $133 | $10 |
| Furosemide | 18 | $128 | $7 |
| Azithromycin | 13 | $124 | $10 |
| Famotidine | 12 | $109 | $9 |
| Ciprofloxacin | 14 | $105 | $8 |
| Atenolol | 23 | $103 | $4 |
| Zolpidem | 13 | $102 | $8 |
| Metoprolol | 13 | $95 | $7 |
| Hydrochlorothiazide | 18 | $86 | $5 |
| Allopurinol | 15 | $72 | $5 |
Money from drug and device companies
$29 in 2024
| 2024 | 1 | 1 | None | $29 |
| 2022 | 3 | 3 | None | $87 |
| 2021 | 5 | 7 | None | $183 |
| 2020 | 5 | 6 | None | $130 |
| 2019 | 8 | 20 | None | $424 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boehringer Ingelheim Pharmaceuticals | Ofev | $29 | 1 payment
|
See the published payment
| Boehringer Ingelheim Pharmaceuticals | Meals · 2024-11-21 | Ofev | $29 |
See earlier years (2022, 2021, 2020, 2019)
2022: $87
| Fidia Pharma USA | Hymovis | $46 | 1 payment
|
| Hikma Pharmaceuticals USA | Kloxxado | $24 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $18 | 1 payment
|
2021: $183
| Pacira Therapeutics | Zilretta | $100 | 2 payments
|
| Indivior | Sublocade | $27 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $23 | 1 payment
|
| Forte Bio-Pharma | Nalocet | $20 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $13 | 1 payment
|
2020: $130
| Amgen | Evenity | $52 | 2 payments
|
| Nabriva Therapeutics plc | Xenleta | $22 | 1 payment
|
| Fidia Pharma USA | Hyalgan | $21 | 1 payment
|
| Radius Health | Tymlos | $19 | 1 payment
|
| US WorldMeds | Lucemyra/Lofexidine | $16 | 1 payment
|
2019: $424
| Amgen | Evenity | $155 | 5 payments
|
| Indivior | Sublocade | $100 | 6 payments
|
| Orexo US | Zubsolv | $54 | 3 payments
|
| US WorldMeds | Lucemyra/Lofexidine | $44 | 2 payments
|
| Medline Industries | None | $25 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $23 | 1 payment
|
| Zyla Life Sciences | Sprix | $12 | 1 payment
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $11 | 1 payment
|
Professional record
- NPI
- 1194826909
- Licence
- CA A64717California A64717: Current · expires 2027-06-30
- Trained
- Temple University School of Medicine, 1995
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A647170
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 16400 Lark Ave, Ste 300, Los Gatos, CA, 95032
- NPI first listed
- 2006-09-26
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.